Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections

Diagnostic Microbiology and Infectious Disease

Volumn 46, Issue 3, 2003, Pages 227-231

  Girmenia, Corrado ^a   Venditti, Mario ^a   Martino, Pietro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; FLUCYTOSINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; CASE REPORT; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0037628306     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00064-6     Document Type: Article

References (20)

1. Atkinson B.A., Bouthet C., Bocanegra R., Correa A., Luther M.F., Graybill J.R. Comparison of Flu, AmB and 5FC in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice. J Antimicrob Chem. 35:1995;631-640.
2. Denning D.W., Baily G.G., Hood S.V. Azole resistance in Candida. Eur J Clin Microbiol Inf Dis. 16:1997;261-280.
3. Ernst E.J., Klepser M.E., Pfaller M.A. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans effect of concentration on exposure time . Diagn Microbiol Infect Dis. 32:1998;205-210.
4. Ghannoum M.A., Fu Y., Ibrahim A.S., Mortara L.A., Shafiq M.C., Edwards J.E. Jr., Criddle R.S. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother. 39:1995;2459-2465.
5. Graybill J.R., Najvar L.K., Holmberg J.D., Luther M.F. Flu, D0870, and 5FC treatment of disseminated Candida tropicalis infections in mice. Antimicrob Agents Chemother. 39:1995;924-929.
6. Klepser M.E., Wolfe E.J., Jones R.N., Nightingale C.H., Pfaller M.A. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Chemother. 41:1997;1392-1395.
7. Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., Winn W.C. Jr. Antimicrobial susceptibility testing, 4th ed. Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.M., Winn W.C. Jr. Diagnostic microbiology. 1992;608-668 J. B. Lippincott Company, Philadelphia, PA.
8. Lacson J.A.S., Raffalli J., Aguero-Rosenfeld M.E., Wormser G.P. Failure of a lipid amphotericin B preparation to eradicate candiduria preliminary findings based on three cases . Clin Infect Dis. 29:1999;686-687.
9. Larsen R.A., Bozzette S.A., Jones B.E., Haghighat D., Leal M.A., Forthal D., Bauer M., Tilles J.G., McCutchan J.A., Leedom J.M. Flu combined with 5FC for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 19:1994;741-745.
10. Lee J.W., Amantea M.A., Francis P.A., Navarro E.E., Bacher J., Pizzo P.A., Walsh T.J. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother. 38:1994;713-718.
11. Louie A., Liu W., Miller D.A., Sucke A.C., Liu Q.F., Drusano G.L., Mayers M., Miller M.H. Efficacies of high-dose Flu plus AmB and high-dose Flu plus 5-fluorocytosine versus AmB, Flu, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans. Antimicrob Agents Chemother. 43:1999;2831-2840.
12. Marr B., Gross S., Cunningham C., Weiner L. Candidal sepsis and meningitis in a very-low-birth-weght infant successfully treated with Flu and 5FC. Clin Infect Dis. 19:1994;795-796.
13. Mayanja-Kizza H., Oishi K., Mitarai S., Yashita H., Nalongo K., Watanabe K., Izuni T., Jungala O., Augustine K., Mugerwa R., Nagatake T., Matsumoto K. Combination therapy with Flu and 5FC for cryptococcal meningitis in ugandan patients with AIDS. Clin Infect Dis. 26:1998;1362-1366.
14. Mikami Y., Scalarone G.M., Kurita N., Yazawa K., Uno J., Miyaji M. Synergistic postantifungal effect of 5FC and Flu on Candida albicans. J Med Vet Mycol. 30:1992;197-206.
15. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Nguyen M.H., Barchiesi F., McGough D.A., Yu V.L., Rinaldi M.G. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var neoformans. Antimicrob Agents Chemother. 39:1995;1691-1695.
17. Nguyen M.H., Najvar L.K., Yu C.Y., Graybill J.R. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Antimicrob Agents Chemother. 41:1997;1120-1123.
18. Scheven M., Junemann K., Schramm H., Huhn W. Successful treatment of a Candida albicans sepsis with a combination of 5FC and Flu. Mycoses. 35:1992;315-316.
19. Scholer H.J., Polak A. Resistance to antifungal agents. Bryan L.E. Antimicrobial drug resistance. 1984;393-460 Academic Press, Orlando.
20. Summers K.K., Hardin T.C., Gore S.J., Graybill J.R. Theapeutic drug monitoring of systemic antifungal theapy. J Antimicrob Chemother. 40:1997;753-764.